Download Files:
Products Details
Product Description
– HBV-IN-33 (C-49), a HBV inhibitor, notably suppresses HBV replication in HepAD38, HepG2-HBV1.3 and HepG2-NTCP cells[1].
Web ID
– HY-149815
Shipping
– Room temperature
Molecular Formula
– C24H29F4N3O5S
References
– [1]Jiaxin Yin, et al. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice. Eur J Med Chem. 2023 Mar 5;249:115141.
Molecular Weight
– 547.56
SMILES
– O=C(C1=C(C)N(CC(F)(F)F)C(C)=C1S(=O)(N2CCC[C@@H](C2)C(NC3=CC=C(C(C)=C3)F)=O)=O)OCC
Clinical Information
– No Development Reported
Research Area
– Infection; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
